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Abstract
Objective: To analyze the clinical, etiological, and epidemiological aspects of community-acquired pneumonia 
(CAP) in hospitalized individuals. Methods: We prospectively studied 66 patients (> 14 years of age) with CAP 
admitted to the Hospital Estadual Sumaré, located in the Sumaré microregion of Brazil, between October of 
2005 and September of 2007. We collected data related to clinical history, physical examination, pneumonia 
severity index (PSI) scores, and laboratory tests (blood culture; sputum smear microscopy and culture; serology for 
Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila; and detection of Legionella 
sp. and Streptococcus pneumoniae antigens in urine). Results: The mean age of patients was 53 years. Most had 
a low level of education, and 55.7% presented with at least one comorbidity at the time of hospitalization. The 
proportion of elderly people vaccinated against influenza was significantly lower among the inpatients than in 
the general population of the Sumaré microregion (52.6% vs. > 70%). Fever was less common among the elderly 
patients (p < 0.05). The clinical evolution was associated with the PSI scores but not with age. The etiology was 
confirmed in 31 cases (50.8%) and was attributed to S. pneumoniae, principally detected by the urinary antigen 
test, in 21 (34.4%), followed by C. pneumoniae, in 5 (8.2%). The mortality rate was 4.9%, and 80.3% of the 
patients were classified as cured at discharge. Conclusions: The knowledge of the etiologic profile of CAP at 
the regional level favors the appropriate choice of empirical treatment, which is particularly relevant in elderly 
patients and in those with comorbidities. The lack of influenza vaccination in elderly patients is a risk factor for 
hospitalization due to CAP.
Keywords: Chlamydophila pneumoniae; Community-acquired infections; Pneumonia; Streptococcus 
pneumoniae; Influenza vaccines.
Resumo
Objetivo: Analisar aspectos clínicos, etiológicos e epidemiológicos das pneumonias adquiridas na comunidade 
(PAC) em indivíduos internados. Métodos: Foram estudados prospectivamente 66 pacientes com PAC maiores de 
14 anos no Hospital Estadual Sumaré, localizado na cidade de Sumaré (SP), entre outubro de 2005 e setembro 
de 2007. Coletamos dados sobre história clínica, exame clínico, escore pneumonia severity index (PSI) e exames 
laboratoriais (hemocultura, bacterioscopia/cultura de escarro, sorologias para Chlamydophila pneumoniae, 
Mycoplasma pneumoniae e Legionella pneumophila, além de antígenos urinários de Legionella sp. e Streptococcus 
pneumoniae). Resultados: A idade média dos pacientes foi de 53 anos, a maioria tinha baixa escolaridade, e 
55,7% apresentavam pelo menos uma comorbidade no momento da internação. O percentual de idosos vacinados 
contra influenza entre os internados foi significativamente menor que os da comunidade dos municípios da 
microrregião de Sumaré (52,6% vs. > 70%). A febre foi menos frequente entre os idosos (p < 0,05). A evolução 
clínica se associou com o escore PSI, mas não com a idade. A etiologia foi confirmada em 31 (50,8%) dos 
casos, sendo 21 (34,4%) devido a S. pneumoniae, detectado principalmente pelo antígeno urinário; seguido de 
C. pneumoniae, em 5 (8,2%). Receberam alta hospitalar por cura 80,3% dos pacientes. A taxa de letalidade foi de 
4,9%. Conclusões: O conhecimento do perfil etiológico de PAC no âmbito regional favorece a escolha adequada 
da terapia empírica, que é particularmente relevante em pacientes idosos e naqueles com comorbidades. A falta da 
vacinação contra influenza em idosos é um fator de risco de internação por PAC. 
Descritores: Chlamydophila pneumoniae; Infecções comunitárias adquiridas; Pneumonia;  
Streptococcus pneumoniae; Vacinas contra influenza.
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at-risk populations, such as the elderly and 
patients with chronic diseases.(5,14) Some studies 
have investigated the impact of high influenza 
vaccination coverage, showing a reduction in the 
number of hospitalizations for and deaths from 
respiratory infection in the elderly, especially in 
periods of higher viral circulation.(14-17)
The objective of the present study was 
to describe the clinical, epidemiological, 
and etiological profile of CAP in inpatients 
at a general hospital located in a city in 
southeastern Brazil, in order to characterize the 
epidemiological context and treatment of the 
disease in the region.
Methods
This was a prospective sequential study of all 
66 patients with CAP admitted to the Hospital 
Estadual Sumaré between October of 2005 and 
September of 2007. The hospital is located in 
the city of Sumaré, Brazil, and has 226 beds, 
of which 35 are in the clinical medicine ward 
and 10 are in the adult ICU, which is a referral 
center for the Sumaré microregion, an area with 
630,000 inhabitants. This hospital has been 
certified as level III (the highest rating given) by 
the Brazilian National Accreditation Committee, 
which evaluates hospitals within established 
parameters.
The inclusion criteria were as follows: being 
over 14 years of age; having been diagnosed 
with pneumonia (presence of one or more 
symptoms and plain chest X-ray findings 
suggestive of pneumonia); not having used 
immunosuppressive drugs; and not having been 
hospitalized within 72 h prior. The exclusion 
criteria were as follows: being suspected 
of having nosocomial pneumonia; having 
neurological sequelae or dementia; and not 
being able to understand the objectives of the 
study. The patients were invited to participate 
in the study, and all participating patients gave 
written informed consent. The study design was 
approved by the Research Ethics Committee 
of the State University at Campinas School of 
Medical Sciences (Process no. 241/2005).
All 66 cases occurring in the study period 
were prospectively investigated by means of a 
questionnaire applied at the bedside in order to 
complement the information contained in the 
medical charts. In addition, when necessary, 
the case was discussed with the clinician 
Introduction
Community-acquired pneumonia (CAP) is a 
major cause of morbidity and mortality in the 
population, especially among the elderly and 
patients with chronic diseases.(1-3) In Brazil, data 
on the incidence of CAP are sparse, especially 
among adults. Records of hospitalization for 
pneumonia from government statistics, provided 
by the Information Technology Department 
of the Unified Health Care System, indicate 
that pneumonia is the second leading cause 
of hospitalization, accounting for 11.8% of 
all hospitalizations in southeastern Brazil in 
2007.(3,4)
Although a high incidence of CAP is reported 
in Brazil, most studies focus on treatment options 
and on the clinical course of the disease. Little is 
known about the microbiological patterns at the 
local and regional levels or about the patterns 
of CAP severity in adults in Brazil.(5,6) Treatment 
protocols and case management protocols are 
often based on investigations of the disease in 
countries in the northern hemisphere. It should 
be borne in mind that the worldwide multicenter 
antimicrobial surveillance program, known 
as SENTRY, and the Latin American Sistema 
Regional de Vacunas (Regional Vaccination 
System) II program have been a reference for 
guiding therapy in Brazil.(7,8)
Despite advances in diagnostic techniques, 
it is estimated that, in approximately 50% of 
the cases, the etiology remains undefined, 
even in countries where access to etiological 
investigation is part of the protocols for the 
treatment of patients with pneumonia.(9,10)
It is believed that Streptococcus pneumoniae 
is the major etiologic agent of bacterial 
pneumonia in various regions of the world.(5,11,12) 
In addition to pneumococcal infection, infections 
with Haemophilus influenzae, Staphylococcus 
sp., Moraxella catarrhalis, and gram-negative 
aerobic bacilli have been identified, as have 
cases of pneumonia caused by Mycoplasma 
pneumoniae, Chlamydophila pneumoniae, and 
Legionella pneumophila, previously designated 
“atypical”.(8,10,13)
Viruses continue to be etiologic agents that 
are frequently associated with CAP and are 
poorly identified.(11,12) The influenza virus is the 
most common cause of CAP in epidemics of 
viral respiratory infection, having the greatest 
impact on the morbidity and mortality of 
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antibodies are fixed, as are anti-species 
antibodies for control. The immobilized anti-
species antibodies capture the anti-species 
conjugate and form a control band. The antigen 
in the urine sample reacts with the conjugated 
specific antibody and is immobilized on the test 
band region. All positive tests were repeated. 
Etiological confirmation was defined as 
positive results by serology, by culture of a 
sterile specimen, blood, or pleural fluid, or by the 
urinary antigen test. Because they can have an 
effect on decisions regarding treatment, sputum 
smear microscopy results were classified as 
suggestive or highly suggestive. The treatment 
options were presented in order to illustrate the 
profile of the antibiotic therapy instituted.
The proportions found between the study 
variables were compared by chi-square test with 
Yates’ correction, and the level of statistical 
significance was set at 5% (p < 0.05).
Results
Of the 66 patients that met the established 
eligibility criteria for CAP, 5 received a confirmed 
diagnosis of tuberculosis after additional 
investigation and were excluded from the 
analysis.
Table 1 allows the identification of the 
sociodemographic profile of the patients. The 
mean age was 53 years (range: 18-96 years), and 
55 patients (57.3%) were male. Most resided in 
neighboring cities in the Sumaré microregion. 
Regarding education, 19 patients (31.1%) had 
had four or fewer years of schooling and 72.1% 
had had eight or fewer years. Therefore, this was 
a population of patients who had a low level 
of education and worked predominantly in 
construction or in the service sector.
Of the 19  patients ≥ 60 years of age, 
10 (52.6%) reported having received influenza 
vaccination in the preceding year, compared 
with only 2 (11.1%) for pneumococcal 
vaccination. Of the 42 patients < 60 years of age, 
10 (23.8%) reported having been immunized 
against influenza in the preceding year and 
none reported having received pneumococcal 
vaccination, although the latter had been 
formally recommended for 18 (42.9%). Of all 
CAP inpatients for whom vaccination had been 
formally recommended (n = 37), only 12 (32.4%) 
and 2 (5.4%) received influenza vaccination and 
pneumococcal vaccination, respectively.
in charge. We collected sociodemographic 
data (age, gender, level of education, marital 
status, and occupation); data on vaccination 
history, occupational history, alcoholism, and 
smoking; clinical data (signs, symptoms, and 
comorbidities); and data on the clinical course 
of the case (length of hospital stay, outcome, 
and ICU admission). 
The patients were classified in accordance 
with the pneumonia severity index (PSI).(3,18)
The etiological investigation included 
sputum smear microscopy, sputum culture, 
pleural fluid culture, and culture of two blood 
samples collected before the administration 
of antibiotics. Most researchers agree that 
running more than three routine blood cultures 
within 24 h does not significantly increase the 
rate of positive results.(3) Serology (ELISA) was 
performed for C. pneumoniae, M. pneumoniae, 
and L. pneumophila. Results were considered 
positive based on the following parameters: for 
C. pneumoniae, a three times greater titer in the 
second sample or IgG ≥ 0.512 AU/mL in the first 
sample; for M. pneumoniae, IgG > 40 AU/mL or 
positive IgM; and for L. pneumophila, an initial 
titer > 1:256 or a four times greater titer in the 
convalescent phase.(5) In addition, the levels of S. 
pneumoniae and L. pneumophila antigens were 
determined in urine samples.
Three consecutive sputum samples were 
sent for microscopy and culture. In order to 
determine smear adequacy and increase the 
specificity of the methods of microbiological 
investigation, the samples were examined under 
optical microscopy by the method described by 
Bartlett et al. for grading the quality of sputum.
(19) The sputum samples selected for microscopy 
were examined by Gram staining and smeared 
onto media for the culture of aerobic bacteria. 
This was achieve by a semiquantitative technique, 
samples from each patient being cultured on a 
blood agar plate, a chocolate agar plate, and a 
MacConkey agar plate.(20)
Urine samples were collected at the time of 
hospitalization and stored at −20°C, after which 
they were subjected to the Binax NOW® tests 
(Binax Inc., Portland, ME, USA) for S. pneumoniae 
and for L. pneumophila serogroup 1. Both tests 
consist of an immunochromatographic assay 
on a nitrocellulose membrane with distinct 
bands, onto which rabbit anti-Streptococcus 
pneumoniae and anti-Legionella pneumophila 
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In the year preceding the study, the influenza 
vaccination coverage of the elderly was reported 
to be over 70% in the five cities in the Sumaré 
microregion, being even higher (74%) in the 
cities where most of our CAP patients resided 
(Sumaré and Hortolândia).(22) The vaccination 
coverage among the patients ≥ 60 years of 
age was significantly lower among the CAP 
inpatients than in the general population (52.6% 
vs. > 70%; p < 0.05).
At admission, 34 patients (55.7%) were 
found to have at least one chronic disease, and 
chronic diseases were more common in the 
patients ≥ 60 years of age (94.1%; Table 2).
Although the mean length of hospital 
stay was 13.6 days, 34 patients (55.7%) were 
discharged within the first 10 days. The shortest 
hospital stay was 3 days and the longest was 
60 days. Only 5 patients (8.2%) were submitted 
to mechanical ventilation, and 5 (8.2%) were 
transferred to the ICU. A total of 21 patients 
(34.4%) were started on corticosteroid therapy, 
and 17 (27.9%) received oxygen therapy via a 
nasal cannula.
Table 3 shows the major symptoms related 
to pulmonary infection among the patients 
≥ 60  years of age and those < 60 years of 
age. Fever was significantly less prevalent 
among the former (57.9% vs. 88.1%; p < 
0.05). Gastrointestinal symptoms occurred in 
approximately 15% of the patients, especially 
in those < 60 years of age, making it difficult 
to diagnose pneumonia at admission. Preceding 
pulmonary infection, flu symptoms such as 
fever, rhinorrhea, and sore throat were common 
(in 21.4%).
The mortality rate of the CAP inpatients 
was 4.9%. However, by less than 10 days after 
admission, 27 patients (44.3%) were free of 
clinical complications. Although 84.2% of the 
patients ≥ 60 years of age had a PSI of III or 
IV, whereas 69.1% of the patients < 60 years of 
age had a PSI of I or II, there were no deaths 
in the former group and the mortality rate was 
7.1% in the latter (Table 4). The PSI was found 
to be dissociated from disease course among the 
patients < 60 years of age. All 5 individuals who 
required ICU admission were < 60 years of age, 
suggesting more severe profiles. We found that 
32 individuals (34.4%) were in categories I or 
II, that is, theoretically, they could be treated as 
outpatients.
Table 1 - Sociodemographic profile, vaccination 
history, and habits of the individuals diagnosed 
with CAP (n = 61). Hospital Estadual Sumaré, 
October/2005-September/2007.
Variable n (%)
Age bracket, years
< 40 17 (27.9)
40-59 25 (41.0)
≥ 60 19 (31.1)
Gender
Male 33 (54.1)
Female 28 (45.9)
Marital status
Married 34 (55.7)
Single 22 (36.1)
Separated 4 (6.6)
Widowed 1 (1.6)
Level of education
≤ 4 years  of schooling 19 (31.1)
Junior high (complete) 25 (41.0)
High school (complete) 10 (16.4)
College 2 (3.3)
Illiterate 4 (6.6)
No data 1 (1.6)
Current occupation
Industry 1 (1.6)
Agriculture 3 (4.9)
Services 18 (29.6)
Self-employed professional 11 (18.0)
Homemaker/maid/cleaner 10 (16.4)
Student 1 (1.6)
Retired 12 (19.8)
Unemployed 3 (4.9)
Place of residence
Sumaré microregiona 50 (82.0)
Other cities in the state of São Paulo 11 (18.0)
2005/2006 influenza vaccination b
< 60 years (n = 18) 2 (11.1)
≥ 60 years (n = 19) 10 (52.6)
Pneumococcal vaccinationb
< 60 years (n = 18) 0 (0.0)
≥ 60 years (n = 19) 2 (10.5)
Smoking statusc
Smoker 23 (37.7)
Former smoker 16 (27.8)
Nonsmoker 22 (34.5)
Alcoholismd
Yes 13 (21.3)
No 48 (78.7)
aThe Sumaré microregion includes the cities of Sumaré, 
Hortolândia, Monte Mor, Nova Odessa, and Santa Bárbara 
D’Oeste. bThere were 37 patients for whom vaccination 
had been formally recommended. cSmokers were defined 
as individuals who reported smoking every day, regardless 
of the quantity of tobacco smoked. dAlcoholics were 
defined as individuals who reported drinking, on a daily 
basis, more than one bottle of a nondistilled (brewed) 
alcoholic beverage or two or more doses of a distilled 
alcoholic beverage.
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patients (34.4%). In 13 of those 21, the etiology 
was confirmed by the urinary antigen test, and, 
in 8 of them, there was no other test result 
indicative of infection, which added information 
in 13.1% of the cases of pneumonia. The most 
prevalent microorganism in blood cultures and 
sputum cultures was S. pneumoniae. The second 
most common agent was C. pneumoniae, in 5 
cases (8.2%). Neither serology nor the urinary 
antigen test identified L. pneumoniae in any of 
the samples investigated (Table 5).
Positive results were obtained in 8.2% of 
the blood cultures. As shown in Table 5, the 
rate of positivity on sputum smear microscopy 
and sputum culture was 13.3% and 15.5%, 
respectively, considering only the 45 samples 
(73%) determined to be adequate by the method 
described by Bartlett et al.(19)
The antibiotic therapy of choice was the 
clavulanate-amoxicillin combination, which was 
prescribed in 25 patients (73.5%), although it was 
necessary to change the regimen to other classes 
of antibiotics in 13 patients (48.1%) who had 
an unfavorable clinical course and in 5 (14.7%) 
who were discharged within less than 10 days. 
Quinolones, clindamycin, and third-generation 
cephalosporins were also administered, as were 
other combinations.
Discussion
In the present study, most of the patients 
evaluated had a low level of education, 
were socioeconomically disadvantaged, had 
comorbidities associated with pneumonia, and 
resided in the Sumaré microregion, where access 
to ambulatory care can be considered poor and 
resolution rates are low.
The influenza vaccination coverage among 
the CAP inpatients ≥ 60 years of age was 
significantly lower than that reported for their 
area of residence and age bracket, underscoring 
the importance of immunobiology in the 
prevention of hospitalizations for pneumonia.
(21) The capacity to prevent hospitalizations 
and deaths has been described as one of the 
major benefits of the influenza vaccine.(15-17) 
Although pneumococcal vaccination coverage 
has been expanding in Brazil, it is still small 
and insufficient for the at-risk populations. 
Many studies have identified the role of health 
care teams and, especially, that of physician 
recommendation as being determining factors 
Of the 5 patients admitted to the ICU (all of 
whom were < 60 years of age), 2 had chronic 
kidney disease, 1 had liver cirrhosis, and 1 had 
pleural/pericardial effusion. In addition, the 
3 deaths occurred in patients with underlying 
chronic diseases (liver cirrhosis, COPD/
emphysema, and diabetes mellitus, respectively).
Among the patients who had a worse clinical 
course, there were 6 cases (22.2%) of CAP 
caused by S. pneumoniae and 2 cases (0.9%) of 
CAP caused by C. pneumoniae.
The etiology of CAP was defined in 31 
patients (50.8%), and S. pneumoniae was the 
most common agent, being identified in 21 
Table 2 - Chronic diseases associated with 
community-acquired pneumonia at the time 
of hospitalization. Hospital Estadual Sumaré, 
October/2005-September/2007.
Comorbiditya n (%)
At least one chronic disease 34 (55.7)
Diabetes 12 (20.0)
Hypertension 23 (38.3)
Heart diseaseb 11 (18.3)
Lung diseasec 16 (26.7)
Acute/chronic kidney disease 5 (8.1)
aSome individuals presented with more than one  associated 
chronic disease. bHeart disease: ischemic heart disease; 
arrhythmias; and heart failure. cLung disease: COPD; 
asthma; pulmonary emphysema; and pneumoconiosis.
Table 3 - Distribution of the symptoms reported by the 
patients at the time of hospitalization, by age. Hospital 
Estadual Sumaré, October/2005-September/2007.
Symptoma < 60 years ≥ 60 years p*
n = 42 n = 19
n (%) n (%)
Cough 41 (97.6) 17 (89.5) 0.47
Fever 37 (88.1) 11 (57.9) 0.01
Chest pain 31(73.8) 13 (68.4) 0.89
Dyspnea 30(71.4) 18 (94.7) 0.07
Expectoration 25 (61.0) 15 (78.9) 0.28
Malaise 25 (59.5) 14 (73.7) 0.43
Myalgia 25 (59.5) 10 (52.6) 0.86
Wheezing 13 (31.0) 9 (47.4) 0.34
Anorexia 15 (36.6) 5 (26.3) 0.62
Abdominal pain 11 (26.2) 2.(10.5) 0.29
Rhinorrhea 9 (21.4) 4 (21.1) 0.76
Sore throat 9 (21.4) 4 (21.1) 0.76
Vomiting 9 (21.4) 2 (10.5) 0.48
Nausea 8 (19.0) 2 (10.5) 0.64
Diarrhea 4 (9.8) 0 (0.0) 0.29**
aSome individuals presented with more than one symptom 
(n = 61). *p < 0.05; chi-square test. **Fisher’s exact test. 
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the patients evaluated in the present study, 
this prevalence being higher (94.1%) among 
the patients ≥ 60 years of age. Some authors 
have drawn attention to the occurrence of 
complications and clinical decompensation 
of chronic diseases in the presence of 
pulmonary infection, leading to greater severity 
of illness.(1-3)
The results of the present study confirm the 
nonspecific clinical expression of pulmonary 
infection in the elderly,(25,26) especially the low 
rates of fever among such patients. Conversely, 
the presence of rhinorrhea and sore throat (in 
approximately 20% of the patients) in both age 
groups raises the suspicion of viral infection 
preceding bacterial infection.
The PSI classification suggested that a large 
proportion of patients who could be followed as 
of the participation of individuals in vaccination 
campaigns.(22-24)
The high prevalence of cases of pneumonia 
caused by S. pneumoniae in the hospital under 
study and the low vaccination coverage in 
the surrounding region draw attention to the 
incipient use of immunization in general and 
specialized clinical practice.
Proportionally, pneumococcal strains were 
more commonly identified among the patients 
who had a more favorable clinical course, and 
the most common treatment option was the 
clavulanate-amoxicillin combination. This initial 
empirical treatment often needed to be altered 
during hospitalization, especially among the 
patients who had a poor clinical course.
The prevalence of chronic diseases (55.7%) 
was often the reason for hospitalization among 
Table 4 - Clinical course, ICU admission, and outcome in the patients hospitalized for community-acquired 
pneumonia. Hospital Estadual Sumaré, October/2005-September/2007.
Variable < 60 years ≥ 60 years Total p*
n (%) n (%)
Clinical coursea
> 10 days or death 19 (45.2) 8 (42.1) 27 (44.3) 0.95
≤ 10 days 23 (54.8) 11 (57.9) 34 (55.7)
PSI, score
I 11(26.2) 0 (0.0) 11 (0.0) 0.01
II 18 (42.9) 3 (15.8) 21 (34.4)
III 6 (14.3) 8 (42.1) 14 (23.0)
IV 7 (16.7) 8 (42.1) 15 (24.6)
Outcome
Death 3 (7.1) 0 (0) 3 (4.9) 0.47
Cure/referral 39 (92.9) 19 (100) 58 (95.1)
Total 42 (68.9) 19 (31.1) 61 (100)  
PSI: pneumonia severity index. aClinical course: length of hospital stay in days or death. *p < 0.05; chi-square test.
Table 5 - Results of the etiological investigation by positivity on one or more tests, at the time of 
hospitalization, in patients with community-acquired pneumonia (n = 61). Hospital Estadual Sumaré, 
October/2005-September/2007.a
Agent Blood 
culture
Sputum Serologyc Urine  
testd
Total
Smear 
microscopyb
Culture n (%)
Streptococcus pneumoniae 4 4 5 - 13 21 (34.4)
Staphylococcus aureus 1 2 2 - - 2 (3.3)
Chlamydophila pneumoniae - - - 5 - 5 (8.2)
Total identified, n (%) 5 (8.2) 6 (13.3) 7 (15.6) 8 (13.1) 13 (21.3) 31 (50.8)
Other/contaminants - 3 4 - - 6 (9.8)
Undefined etiology, n (%) 26 (42.6)      
aIn some cases, more than one test was positive. bLikely cases: Bartlett’s test and sputum smear microscopy 
(adequate samples, n = 45). cSerology (2 samples) for C. pneumoniae, Mycoplasma pneumoniae, and 
Legionella pneumophila. dDetection of S. pneumoniae antigen in urine.
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smear microscopy nor culture contributed to 
elucidating the etiology of the cases evaluated 
in the present study. Although sputum smear 
microscopy and culture are inexpensive, their 
use as a tool for the etiologic diagnosis of CAP 
is controversial because of their low specificity 
and the large proportion of improperly collected 
samples, which limits their diagnostic power 
in the management of pneumonia.(28,29) It is 
believed that the use of PCR in sputum samples 
can improve the detection of etiologic agents.
(30) However, the present study showed that 
the etiology can be confirmed by detection of 
S. pneumoniae antigen in urine samples. Its 
use as a routine test in cases of pneumonia can 
bring highly relevant benefits to the choice of 
antibiotic therapy, especially in cases of severe 
illness.(3)
Although detection of IgG by ELISA is 
not specific for C. pneumoniae, a three to 
four times greater titer in the second sample, 
collected during the respiratory infection, 
suggests infection with this organism. Despite 
the small absolute number of cases, physicians 
should consider positivity for C. pneumoniae 
(in 8.2%) and M. pneumoniae (in 4.9%) when 
prescribing empirical treatment for patients 
with CAP who reside in this particular region. 
The absence of L. pneumophila-positive cases 
might be attributable to the small number of 
patients analyzed or even to the low prevalence 
of this microorganism in the region. In a study 
of individuals with CAP who were treated as 
outpatients, Rocha et al. found similar results.(5)
Chief among the limitations of the present 
study are the small sample size, the fact that 
the PSI criteria was not used as a variable 
in the decision-making process regarding 
hospitalization, and the fact that other criteria, 
such as the CURB-65 or CRB-65 scores, which 
could identify severe cases missed by the PSI, 
were not used. In addition, no standard treatment 
protocol was followed after the cases were 
diagnosed. Treatment was the responsibility of 
the clinician at the time of hospitalization and 
during routine ward visits. However, the study 
protocol was strictly followed. Therefore, the 
outcome of the pneumonia cases might have 
been affected by treatment decisions and by 
the clinical approach. It is of note that, after 
the results of the present study were made 
known, the routine practice for the treatment 
outpatients were hospitalized, this was especially 
true for 70% of the patients < 60 years of age, 
given that they had a PSI of I or II. However, in 
this age group, there was a higher ICU admission 
rate and a higher mortality rate. Although few 
cases were analyzed, these results suggest that 
the PSI underestimated the severity of illness in 
the CAP patients < 60 years of age.
Conversely, the PSI classified 84% of the CAP 
cases among the patients ≥ 60 years of age as 
cases for hospitalization, although there were 
no deaths and some cases evolved to clinical 
resolution. In the Sumaré microregion, where 
access to health care facilities can be considered 
poor and the resolution rates are assessed as 
low, the teams who first saw the patients opted 
for hospitalization in order to ensure access 
to and the appropriate use of medications, as 
well as the subsequent clinical assessment of 
patients, especially of elderly patients with 
chronic diseases. The low CAP-related mortality 
rate in this hospital might be attributable to this 
admission profile.
Although hospital stays were longer and 
clinical complications were more common in 
the patients ≥ 60 years of age than in those 
< 60 years of age, survival rates were higher 
in the former group. It should be noted that 
the PSI was not used in the decision-making 
process regarding hospitalization at the time of 
admission, which made it difficult to analyze 
this index. In addition, the small sample size 
precludes accurate conclusions about the 
severity of illness or the etiology of the cases.
The etiology of CAP was established in 
31 patients (50.8%), which confirms data 
in the literature showing that the etiologic 
diagnosis is not established in 40-50% of cases 
of pneumonia, despite the use of a number 
of existing microbiological and serological 
methods.(9,11)
In the present study, the proportion of 
positive blood cultures was 8.2%. This might 
be attributable to antibiotic therapy prior to 
hospitalization. Despite being low, the blood 
culture positivity rate found in the present study 
is similar to those reported in other studies 
(5-14%).(10,27)
Despite being performed after the use of 
the qualitative test described by Bartlett et al.
(19) and having their positivity assessed only in 
the properly collected samples, neither sputum 
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Fisman DN. Influenza vaccination and risk of mortality 
among adults hospitalized with community-acquired 
pneumonia. Arch Intern Med. 2007;167(1):53-9.
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acquired bacteremic pneumonia. J Clin Microbiol. 
1988;26(5):846-9.
21. Spaude KA, Abrutyn E, Kirchner C, Kim A, Daley J, 
Fisman DN. Influenza vaccination and risk of mortality 
of CAP cases began to be standardized in the 
hospital under study. Regarding elucidation of 
the diagnosis, loss to clinical follow-up after 
hospital discharge made it impossible to arrive at 
a definitive etiological diagnosis in some cases 
(those in which a second biological sample for 
serology was not collected).
In conclusion, we found that most CAP 
cases in the study region occurred in patients 
< 60 years of age, who had a worse clinical 
course, and that the severity of illness in 
such patients was underestimated by the PSI. 
The mortality rate was low (4.9%) and was 
concentrated among the patients < 60 years of 
age. The hospitalization of individuals that could 
have been followed as outpatients, based on the 
PSI, was justified by the need to ensure access to 
medication and to clinical follow-up, especially 
among the elderly and patients with chronic 
diseases. Not being vaccinated against influenza 
was a risk factor for CAP-related hospitalization 
among the elderly patients evaluated in the 
present study. There are several risk factors 
related to the occurrence and severity of CAP, 
factors that are affected by aspects such as the 
morbidity profile at the local/regional level, the 
specific vaccination coverage, and the circulation 
patterns of pathogens, as well as the level of 
access to and quality of health care. Knowledge 
of these factors in a given region can inform 
therapeutic decisions in cases of pneumonia.
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